Targeting of 3D oral cancer spheroids by αVβ6 integrin using near-infrared peptide-conjugated IRDye 680

World Health Organization. Global oral health status report: towards universal health coverage for oral health by 2030. 2022; http://apps.who.int/bookorders.

Tajmirriahi N, Razavi SM, Shirani S, Homayooni S, Gasemzadeh G. Dental Research Journal Evaluation of metastasis and 5-year survival in oral squamous cell carcinoma patients in Isfahan (2001–2015). Dent Res J (Isfahan). 2019;16:117–21.

Article  PubMed  Google Scholar 

Gupta S, Kumar P, Das BC. HPV + ve/–ve oral-tongue cancer stem cells: a potential target for relapse-free therapy. Transl Oncol. 2021;14:100919.

Article  CAS  PubMed  Google Scholar 

Elaiwy O, El Ansari W, AlKhalil M, Ammar A. Epidemiology and pathology of oral squamous cell carcinoma in a multi-ethnic population: retrospective study of 154 cases over 7 years in Qatar. Ann Med Surg (London). 2020;60:195–200.

Article  Google Scholar 

Wang B, Zhang S, Yue K, Wang XD. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J Cancer. 2013;32:614–8.

Article  PubMed  PubMed Central  Google Scholar 

Bodner L, Manor E, Friger MD, Van Der Waal I. Oral squamous cell carcinoma in patients twenty years of age or younger - review and analysis of 186 reported cases. Oral Oncol. 2014;50:84–9.

Article  PubMed  Google Scholar 

Nicoletti G, Soutar DS, Jackson MS, Wrench AA, Robertson G. Chewing and swallowing after surgical treatment for oral cancer: functional evaluation in 196 selected cases. Plast Reconstr Surg. 2004;114:329–38.

Article  PubMed  Google Scholar 

Son YR, Choi KH, Kim TG. Dysphagia in tongue cancer patients. Ann Rehabil Med. 2015;39:210–7.

Article  PubMed  PubMed Central  Google Scholar 

Azari F, Kennedy G, Bernstein E, Hadjipanayis C, Vahrmeijer AL, Smith BL et al. Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings. J Biomed Opt. 2021;26.

Pan J, Deng H, Hu S, Xia C, Chen Y, Wang J, et al. Real-time surveillance of surgical margins via ICG-based near-infrared fluorescence imaging in patients with OSCC. World J Surg Oncol. 2020;18:96.

Article  PubMed  PubMed Central  Google Scholar 

Cortese S, Kerrien E, Yakavets I, Meilender R, Mastronicola R, Renard S et al. ICG-induced NIR fluorescence mapping in patients with head & neck tumors after the previous radiotherapy. Photodiagnosis Photodyn Ther. 2020;31.

Gao RW, Teraphongphom NT, van den Berg NS, Martin BA, Oberhelman NJ, Divi V, et al. Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence. Cancer Res. 2018;78:5144–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Keulen S, Nishio N, Fakurnejad S, van den Berg NS, Lu G, Birkeland A, et al. Intraoperative Tumor Assessment Using Real-Time Molecular Imaging in Head and Neck Cancer patients. J Am Coll Surg. 2019;229:560–e5671.

Article  PubMed  Google Scholar 

Rehmani HS, Issaeva N. EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations. Ann Transl Med. 2020;8:813–813.

Article  PubMed  PubMed Central  Google Scholar 

De Boer E, Warram JM, Tucker MD, Hartman YE, Moore LS, De Jong JS et al. In vivo fluorescence immunohistochemistry: localization of fluorescently labeled Cetuximab in squamous cell carcinomas. Sci Rep. 2015;5.

Rosenthal EL, Warram JM, De Boer E, Chung TK, Korb ML, Brandwein-Gensler M, et al. Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer. Clin Cancer Res. 2015;21:3658–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marsico G, Russo L, Quondamatteo F, Pandit A. Glycosylation and integrin regulation in Cancer. Trends Cancer Cell Press. 2018;4(8):537–52.

Article  CAS  Google Scholar 

Ahmedah HT, Patterson LH, Shnyder SD, Sheldrake HM. RGD-binding integrins in head and neck cancers. Cancers (Basel). MDPI AG; 2017.

Su CY, Li JQ, Zhang LL, Wang H, Wang FH, Tao YW, et al. The Biological functions and clinical applications of integrins in cancers. Front Pharmacol. Frontiers Media S.A.; 2020.

Li HX, Zheng JH, Fan HX, Li HP, Gao ZX, Chen D. Expression of αvβ6 integrin and collagen fibre in oral squamous cell carcinoma: Association with clinical outcomes and prognostic implications. J Oral Pathol Med. 2013;42:547–56.

Article  CAS  PubMed  Google Scholar 

Thomas GJ, Nyström ML, Marshall JF. αvβ6 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med. 2006;35:1–10.

Article  CAS  PubMed  Google Scholar 

Baart VM, van Duijn C, van Egmond SL, Dijckmeester WA, Jansen JC, Vahrmeijer AL, et al. Egfr and αvβ6 as promising targets for molecular imaging of cutaneous and mucosal squamous cell carcinoma of the head and neck region. Cancers (Basel). 2020;12:1474.

Article  CAS  PubMed  Google Scholar 

Xue H, Atakilit A, Zhu W, Li X, Ramos DM, Pytela R. Role of the αvβ6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun. 2001;288:610–8.

Article  CAS  PubMed  Google Scholar 

Khan Z, Marshall JF. The role of integrins in TGFβ activation in the tumour stroma. Cell Tissue Res Springer Verlag. 2016;365:657–73.

Article  CAS  Google Scholar 

Marsh D, Suchak K, Moutasim KA, Vallath S, Hopper C, Jerjes W, et al. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol. 2011;223:470–81.

Article  CAS  PubMed  Google Scholar 

Kapp TG, Rechenmacher F, Neubauer S, Maltsev OV, Cavalcanti-Adam EA, Zarka R et al. A comprehensive evaluation of the activity and selectivity profile of ligands for RGD-binding integrins. Sci Rep. 2017;7.

Cardle II, Jensen MC, Pun SH, Sellers DL. Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targeting. J Biol Chem. 2021;296:100657.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hausner SH, DiCara D, Marik J, Marshall JF, Sutcliffe JL. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin αvβ6 expression with positron emission tomography. Cancer Res. 2007;67:7833–40.

Article  CAS  PubMed  Google Scholar 

Meecham A, Marshall J. Harnessing the power of foot-and-mouth-disease virus for targeting integrin alpha-v beta-6 for the therapy of cancer. Volume 16. Expert Opin Drug Discov. Taylor and Francis Ltd.; 2021. pp. 737–44. 7.

Hausner SH, Abbey CK, Bold RJ, Gagnon MK, Marik J, Marshall JF, et al. Targeted in vivo imaging of integrin αvβ6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res. 2009;69:5843–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ganguly T, Tang SY, Bauer N, Sutcliffe JL. Evaluation of two Optical Probes for Imaging the integrin αvβ6 – in Vitro and in vivo in Tumor-Bearing mice. Mol Imaging Biol. 2020;22:1170–81.

Article  CAS  PubMed  Google Scholar 

Tosca EM, Ronchi D, Facciolo D, Magni P. Replacement, reduction, and refinement of animal experiments in Anticancer Drug Development: the contribution of 3D in Vitro Cancer models in the drug Efficacy Assessment. Biomedicines. 2023;11(4):1058.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hockney S, Parker J, Turner JE, Todd X, Todryk S, Gieling RG, et al. Next generation organoid engineering to replace animals in cancer drug testing. Biochem Pharmacol. Elsevier Inc.; 2023.

Francois A, Dirheimer L, Chateau A, Lassalle HP, Bezdetnaya L, Yakavets I. A macrophages-enriched Head and Neck Tumor Spheroid Model to Study Foslip® Behavior in Tumor Microenvironment. Int J Nanomed. 2023;18:6545–62.

Article  CAS  Google Scholar 

Arutyunyan I, Jumaniyazova E, Makarov A, Fatkhudinov T. In Vitro models of Head and Neck Cancer: from primitive to most Advanced. J Pers Med. 2023;13:1575.

Article  PubMed  PubMed Central  Google Scholar 

Liu C, Mak M. Fibroblast-mediated uncaging of cancer cells and dynamic evolution of the physical microenvironment. Sci Rep. 2022;12.

Qian L-W, Mizumoto K, Maehara N, Ohuchida K, Inadome N, Saimura M et al. Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts: fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production [Internet]. www.elsevier.com/locate/canlet.

Lee C, Lee C, Atakilit A, Siu A. M.Ramos D. Differential spheroid formation by oral cancer cells. Anticancer Res. 2014;34:6945–9.

CAS  PubMed  Google Scholar 

Andreiuk B, Reisch A, Lindecker M, Follain G, Peyriéras N, Goetz JG et al. Fluorescent polymer nanoparticles for cell barcoding in Vitro and in vivo. Small. 2017;13.

Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: a portal for facilitating Tumor Subgroup Gene expression and survival analyses. Neoplasia. 2017;19:649–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif